RONALD HOFFMAN
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology NEW YORK, NY NPI 1467558932
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology NY Sumitomo Pharma America, Inc. All categories
General Payments — all program years on this page
$19,158.90
- Category: General Payments
- Program years: PY2018–2024
- Record count: 31
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,147.20 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $1,950.00 | 1 |
| Food and Beverage | $197.20 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Sumitomo Pharma America, Inc. | $1,950.00 | 1 |
| Blueprint Medicines Corporation | $132.83 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $45.62 | 2 |
| GlaxoSmithKline, LLC. | $18.75 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086881979 | Novartis Pharmaceuticals Corporation | $23.70 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086882011 | Novartis Pharmaceuticals Corporation | $21.92 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116605754 | GlaxoSmithKline, LLC. | $18.75 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147454549 | Blueprint Medicines Corporation | $32.28 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147454567 | Blueprint Medicines Corporation | $32.46 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147454577 | Blueprint Medicines Corporation | $35.99 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147454613 | Blueprint Medicines Corporation | $32.10 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1148865227 | Sumitomo Pharma America, Inc. | $1,950.00 | 08/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.